IDiyas

For the Inventor, By the Inventor

East Brunswick, NJ, United States of America

Nancy J Kevin

USPTO Granted Patents = 15 



Average Co-Inventor Count = 5.5

ph-index = 6

Forward Citations = 106(Granted Patents)


Location History:

  • Clifton, NJ (US) (1993 - 1998)
  • East Brunswick, NJ (US) (2003 - 2022)

Company Filing History:

goldMedal8 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal6 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 1 
 
Merck Sharp & Dhome Corp.
 patent

Years Active: 1993-2022

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):
1. 11530250 - Tyrosine-specific functionalized insulin and insulin analogs (2022-12-20),
2. 10093683 - Factor XIa inhibitors (2018-10-09),
3. 9676723 - Factor XIa inhibitors (2017-06-13),
4. 8178546 - Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 (2012-05-15),
5. 7981910 - Triazole derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase-1 (2011-07-19),
6. 7932280 - Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 (2011-04-26),
7. 7659408 - Pyrazole carboxamides as inhibitors of 11-β-hydroxysteroid dehydrogenase-1 (2010-02-09),
8. 6642237 - Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof (2003-11-04),
9. 5767310 - Phenoxyphenylacetic acid derivatives (1998-06-16),
10. 5668176 - Phenoxyphenylacetic acid derivatives (1997-09-16),
11. 5565485 - Biphenyl compounds useful or endothelin antagonists (1996-10-15),
12. 5554625 - Substituted biphenylmethylimidazopyridines (1996-09-10),
13. 5252574 - Angiotensin II antagonists incorporating a substituted thiophene or furan (1993-10-12),
14. 5198438 - Angiotensin II antagonists incorporating a substituted thiophene or furan (1993-03-30),
15. 5177074 - Angiotensin II antagonists incorporating a substituted thiophene or furan (1993-01-05),

Certainly! Here is the article about inventor Nancy J Kevin:

Title: Nancy J Kevin: Pioneering Innovations in Technology

Introduction:

Nancy J Kevin is a visionary inventor based in East Brunswick, NJ, whose dedication to innovation has made her a true trailblazer in the field of inventions. With a remarkable portfolio of 15 patents, Nancy's contributions to the world of technology have been nothing short of groundbreaking.

Latest Patents:

Among Nancy's latest patents are the Tyrosine-specific functionalized insulin and insulin analogs, which revolutionize the production of insulin analogs. Additionally, her Factor XIa inhibitors have opened new possibilities in treating thromboses, embolisms, and hypercoagulability through innovative pharmaceutical compositions.

Career Highlights:

Nancy J Kevin has made significant strides in her career, notably working with renowned companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. Her expertise and innovative mindset have led to the development of cutting-edge technologies that continue to shape the future of the tech industry.

Collaborations:

Throughout her career, Nancy has collaborated with industry experts like Ralph A Rivero and Prasun K Chakravarty, further enhancing her innovative projects and fostering a culture of creativity and excellence in her work.

Conclusion:

In conclusion, Nancy J Kevin's passion for innovation and her outstanding contributions to the field of technology highlight her as a pioneering inventor. Her patents and collaborations serve as a testament to her unwavering commitment to pushing the boundaries of what is possible in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…